Search research articles
Contact Us
Filters
Showing results (51-60 of 125) with videos related to
Page
of 13
Sort By:
Journal of Nutrition in Gerontology and Geriatrics
|
April 25, 2019
Identifying Geriatric Patients at Risk for Malnutrition: A Quality Improvement Project
Lauren C Mays, Jennifer W Drummonds, Summer Powers, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1987
Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans
D C Mays, C Camisa, P Cheney, et al.
Biochemical Pharmacology
|
February 21, 1997
Inhibition of aldehyde dehydrogenase by disulfiram and its metabolite methyl diethylthiocarbamoyl-sulfoxide
K A Veverka, K L Johnson, D C Mays, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1986
Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics
C A Beach, D C Mays, R C Guiler, et al.
Evaluation and Program Planning
|
March 17, 2022
Application of the Indigenous evaluation framework to a university certificate program for building cultural awareness in science, technology, engineering, and mathematics
Christine Velez, Bridget Nuechterlein, Susan Connors, et al.
Alcoholism, Clinical and Experimental Research
|
May 1, 1996
S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiram
D C Mays, A N Nelson, J Lam-Holt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1990
Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans
G Apseloff, D R Shepard, M A Chambers, et al.
The Review of Scientific Instruments
|
December 3, 2015
Measurement of colloidal phenomena during flow through refractive index matched porous media
Eric J Roth, Michael E Mont-Eton, Benjamin Gilbert, et al.
Inflammatory Bowel Diseases
|
August 24, 1999
Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexate
L J Egan, W J Sandborn, D C Mays, et al.
Inflammatory Bowel Diseases
|
January 10, 2001
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease
L J Egan, W J Tremaine, D C Mays, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 125) with videos related to
Sort By:
Page
of 13
Journal of Nutrition in Gerontology and Geriatrics
|
April 25, 2019
Identifying Geriatric Patients at Risk for Malnutrition: A Quality Improvement Project
Lauren C Mays, Jennifer W Drummonds, Summer Powers, et al.
Clinical Pharmacology and Therapeutics
|
December 1, 1987
Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans
D C Mays, C Camisa, P Cheney, et al.
Biochemical Pharmacology
|
February 21, 1997
Inhibition of aldehyde dehydrogenase by disulfiram and its metabolite methyl diethylthiocarbamoyl-sulfoxide
K A Veverka, K L Johnson, D C Mays, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1986
Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics
C A Beach, D C Mays, R C Guiler, et al.
Evaluation and Program Planning
|
March 17, 2022
Application of the Indigenous evaluation framework to a university certificate program for building cultural awareness in science, technology, engineering, and mathematics
Christine Velez, Bridget Nuechterlein, Susan Connors, et al.
Alcoholism, Clinical and Experimental Research
|
May 1, 1996
S-methyl-N,N-diethylthiocarbamate sulfoxide and S-methyl-N,N-diethylthiocarbamate sulfone, two candidates for the active metabolite of disulfiram
D C Mays, A N Nelson, J Lam-Holt, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 1, 1990
Inhibition and induction of theophylline metabolism by 8-methoxypsoralen. In vivo study in rats and humans
G Apseloff, D R Shepard, M A Chambers, et al.
The Review of Scientific Instruments
|
December 3, 2015
Measurement of colloidal phenomena during flow through refractive index matched porous media
Eric J Roth, Michael E Mont-Eton, Benjamin Gilbert, et al.
Inflammatory Bowel Diseases
|
August 24, 1999
Plasma and rectal adenosine in inflammatory bowel disease: effect of methotrexate
L J Egan, W J Sandborn, D C Mays, et al.
Inflammatory Bowel Diseases
|
January 10, 2001
Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease
L J Egan, W J Tremaine, D C Mays, et al.
Page
of 13